 Labetalol
"Labetalol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
| Descriptor ID |
D007741
|
| MeSH Number(s) |
D02.033.100.291.460 D02.065.793.324 D02.092.063.291.460
|
| Concept/Terms |
Albetol- Albetol
- Leiras Brand of Labetalol Hydrochloride
Apo-Labetalol- Apo-Labetalol
- Apo Labetalol
- ApoLabetalol
- Apotex Brand of Labetalol Hydrochloride
Dilevalol- Dilevalol
- R,R-Labetalol
- R,R Labetalol
- Labetalol, (R,R)-Isomer
Normodyne- Normodyne
- Schering Brand of Labetalol Hydrochloride
Presolol- Presolol
- Alphapharm Brand of Labetalol Hydrochloride
Trandate- Trandate
- Faro Brand of Labetalol Hydrochloride
- Sigma Brand of Labetalol Hydrochloride
- GlaxoSmithKline Brand of Labetalol Hydrochloride
- Kern Brand of Labetalol Hydrochloride
- Shire Brand of Labetalol Hydrochloride
- Celltech Brand of Labetalol Hydrochloride
- Glaxo Wellcome Brand of Labetalol Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Labetalol".
Below are MeSH descriptors whose meaning is more specific than "Labetalol".
This graph shows the total number of publications written about "Labetalol" by people in this website by year, and whether "Labetalol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2011 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Labetalol" by people in Profiles.
-
Fischer JH, Sarto GE, Hardman J, Endres L, Jenkins TM, Kilpatrick SJ, Jeong H, Geller S, Deyo K, Fischer PA, Rodvold KA. Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy. Clin Pharmacokinet. 2014 Apr; 53(4):373-83.
-
Sherman L, Niemann J, Youngquist ST, Shah AP, Rosborough JP. Beta-blockade causes a reduction in the frequency spectrum of VF but improves resuscitation outcome: A potential limitation of quantitative waveform measures. Resuscitation. 2012 Apr; 83(4):511-6.
-
Bakris G. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade. J Cardiovasc Pharmacol. 2009 May; 53(5):379-87.
-
Hernandez MR, Shamberger RC, Seefelder C. Catecholamine-secreting neuroblastoma in a 4-month-old infant: perioperative management. J Clin Anesth. 2009 Feb; 21(1):54-6.
-
Tung A, Sweitzer B, Cutter T. Cardiac arrest after labetalol and metoclopramide administration in a patient with scleroderma. Anesth Analg. 2002 Dec; 95(6):1667-8, table of contents.
-
Zell-Kanter M, Leikin JB. Oral labetalol in hypertensive urgencies. Am J Emerg Med. 1991 Mar; 9(2):136-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|